Cell therapy for the diseased liver: from stem cell biology to novel models for hepatotropic human pathogens.
It has long been known that hepatocytes possess the potential to replicate through many cell generations because regeneration can be achieved in rodents after serial two-thirds hepatectomy. It has taken considerable time and effort to harness this potential, with liver regeneration models involving hepatocyte transplantation developing over the past 15 years. This review will describe the experiments that have established the models and methodology for liver repopulation, and the use of cells other than adult hepatocytes in liver repopulation, including hepatic cell lines and hematopoietic, cord blood, hepatic and embryonic stem cells. Emphasis will be placed on the characteristics of the models and how they can influence the outcome of the experiments. Finally, an account of the development of murine models that are competent to accept human hepatocytes is provided. In these models, liver deficiencies are induced in immunodeficient mice, where healthy human cells have a selective advantage. These mice with humanized livers provide a powerful new experimental tool for the study of human hepatotropic pathogens.
Brezillon
Nicolas
N
INSERM, U845, Pathogenèse des Hépatites Virales B et Immunothérapie, Paris 75015, France.
Kremsdorf
Dina
D
Weiss
Mary C
MC
D000818:Animals; D001854:Bone Marrow Cells / Q000166:cytology; D017690:Cell Transplantation; D005312:Fetal Blood / Q000166:cytology; D006801:Humans; D008099:Liver / Q000166:cytology / Q000196:embryology; D008107:Liver Diseases / Q000503:physiopathology / Q000628:therapy*; D008115:Liver Regeneration; D051379:Mice; D013234:Stem Cells